Sarah Milczarek, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 Alexandria Pike Ste 100, Southgate, KY 41071 Phone: 888-795-5826 |
Quintin Hauser Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 Alexandria Pike Ste 100, Southgate, KY 41071 Phone: 888-795-5826 |
Richard Charles Vogel Iii, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 Alexandria Pike Ste 100, Southgate, KY 41071 Phone: 888-795-5826 |
Dr. Meredith Beard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 525 Alexandria Pike Ste 100, Southgate, KY 41071 Phone: 888-795-5826 |
News Archive
Our heart is constantly beating yet we normally do not feel it. It turns out that our brain is capable of filtering out the cardiac sensation so that it doesn't interfere with the brain's ability to perceive external sensations. For the first time, researchers from the Center for Neuroprosthetics at EPFL have identified this mechanism. They discovered that a certain region in the brain determines where internal and external sensations interact. Their work appears in the Journal of Neuroscience.
California Attorney General Bill Lockyer issued the following statement on this week's ruling by the U.S. Supreme Court in Gonzales v. Raich, which holds that federal laws prohibiting the use of medical marijuana remain in effect regardless of state laws that permit its use:
TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings using ozone, today announced that documentation supplied to the European Notified Body conforms to the new Medical Device Directive for Class IIb medical devices; an enhanced European standard to be enforced starting April 2010. This notification allows the Company to label its new generation sterilizers with the CE Mark, which is a requirement to place products in the European Union; the second largest sterilization market after the United States.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that an oral presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) will feature Phase 2 trial data with tivantinib as a single agent investigational second-line treatment in hepatocellular carcinoma (HCC).
NuGEN Technologies, the provider of innovative RNA and DNA sample preparation solutions for genomic analysis, today announced the availability of the Ovation WGA FFPE System and the Ovation RNA-Seq FFPE System. These are the first commercially available products designed specifically to enable researchers to utilize next-generation sequencing (NGS) technologies to analyze nucleic acids extracted from Formalin-Fixed Paraffin-Embedded (FFPE) tissues.
› Verified 6 days ago